A carregar...
Profile of olaparib in the treatment of advanced ovarian cancer
Olaparib is a poly(ADP-ribose) polymerase inhibitor that received accelerated approval from the US Food and Drug Administration as monotherapy for patients with germline BRCA mutations and ovarian cancer treated with three or more prior lines of chemotherapy. This article summarizes the mechanism of...
Na minha lista:
| Publicado no: | Int J Womens Health |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847603/ https://ncbi.nlm.nih.gov/pubmed/27186080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S55906 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|